Abstract / Description of output
There is currently a lack of consensus and uncertainty about whether one should adjust for multiple testing in multi-arm trials of distinct treatments. A detailed rationale is presented to justify non-adjustment in this situation. We argue that non-adjustment should be the default starting position in simple multi-arm trials of distinct treatments.
| Original language | English |
|---|---|
| Pages (from-to) | 1740774520941419 |
| Journal | Clinical Trials |
| DOIs | |
| Publication status | Published - 15 Jul 2020 |
Fingerprint
Dive into the research topics of 'Non-adjustment for multiple testing in multi-arm trials of distinct treatments: rationale and justification'. Together they form a unique fingerprint.Profiles
-
Richard Parker
- Deanery of Molecular, Genetic and Population Health Sciences - Senior Research Fellow
- Usher Institute
- Edinburgh Clinical Trials Unit
- Centre for Population Health Sciences
Person: Academic: Research Active